Orchestra BioMed Holdings, Inc. (OBIO) Net margin 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-157.4%FY2025 · since FY2022: -951.3% → -157.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -157.4% | +2155.9 pp |
| FY2024 | -2313.3% | -533.6 pp |
| FY2023 | -1779.7% | -828.5 pp |
| FY2022 | -951.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice